Immune-modulating and anti-inflammatory marine compounds against cancer

Cristina Florean1, Mario Dicato1, Marc Diederich2

  • 1Laboratoire de Biologie Moléculaire et Cellulaire du Cancer, Hôpital Kirchberg, L-2540 Luxembourg.

Seminars in Cancer Biology
|February 20, 2020
PubMed

Insights

Marine compounds show promise for cancer immunotherapy by modulating the immune system. This review explores their potential in cancer prevention, treatment, and enhancing immune responses against tumors.

Area of Science:

  • Marine biology
  • Immunology
  • Pharmacology

Background:

  • The tumor microenvironment often features chronic inflammation and suppressed immune surveillance, hindering cancer progression and treatment.
  • Cancer immunotherapy leverages the immune system to fight cancer, with many drugs' efficacy linked to immune modulation.
  • Marine organisms are a source of novel bioactive molecules with therapeutic potential, including anticancer applications.

Purpose of the Study:

  • To review the immune-modulatory properties of marine compounds.
  • To explore their potential in cancer prevention and treatment.
  • To assess their utility as tools in cancer immunotherapy.

Main Methods:

  • Literature review of scientific publications.
  • Analysis of studies on marine-derived compounds and their effects on the immune system.
  • Evaluation of preclinical and clinical data on marine compounds in cancer research.

Main Results:

  • Marine compounds exhibit diverse immune-modulatory activities.
  • Several marine-derived molecules show potential for reversing pro-tumor inflammation.
  • Marine compounds can stimulate antitumor immune responses, offering therapeutic benefits.

Conclusions:

  • Marine compounds represent a promising resource for developing novel cancer immunotherapies.
  • Their immune-modulatory properties can be harnessed for cancer prevention and treatment strategies.
  • Further research into marine-derived molecules could lead to new tools for enhancing cancer immunotherapy.

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.8K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.5K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
403
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.7K